Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fusidic Acid 2% Cream
Therapeutic Category
Antibiotic, Dermatology, Antibacterials
Dosage Form
Cream
Packaging Type
Tube
Packaging
10gm
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fusitrip Cream is a topical antibiotic formulation containing Fusidic Acid 2%, which is highly effective in treating bacterial skin infections. Fusidic Acid is a potent antibiotic that works by inhibiting bacterial protein synthesis, thereby stopping the growth of bacteria and promoting healing. It is especially effective against gram-positive bacteria, including Staphylococcus aureus, making it a trusted solution for managing various dermatological infections.
Fusitrip Cream is widely used to treat conditions such as impetigo, infected eczema, folliculitis, and minor wounds that have become infected. It provides targeted action to reduce redness, swelling, and discomfort associated with bacterial infections. Its fast-acting formula penetrates the skin to deliver quick relief, restoring the skin's health while minimizing the risk of bacterial spread.
The cream is easy to apply and is non-greasy, ensuring patient comfort. Its gentle formulation is suitable for sensitive skin and helps in reducing inflammation while protecting the affected area. Fusitrip Cream is an essential addition to any dermatological treatment plan for bacterial infections, offering a reliable and effective remedy for clear and healthy skin.
Generally well-tolerated. Rare side effects may include nausea, constipation, or mild allergic reactions.
For the treatment of acidity, heartburn, gastric pain, bloating, and ulcers.
Use under medical supervision. Do not exceed the recommended dose. Seek medical advice if symptoms persist.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children. Shake well before use.
Composition : Amorolfine I.P. 0.25% w/w Cream
Composition : Terbinafine, Ciprofloxacin, Metronidazole & Clobetasole Propionate Cream
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Clobetasole 0.05% + Neomycin 0.5% + Miconazole 2%
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Ketoconazole (2% w/w) Cream
Composition : Ketoconazole (2% w/w) + Beclometasone (0.025% w/w)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Fusidic Acid 2% Cream has strong demand in the dermatology and anti-infective skin-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on skin infection and wound-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of bacterial skin infections, impetigo, infected cuts, wounds, boils, and post-surgical skin infections. Fusidic Acid 2% is a topical antibiotic effective against gram-positive bacteria, especially Staphylococcus aureus Helps in quick healing of infected skin conditions and prevents infection spread This strengthens a reliable dermatology and topical anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Fusidic Acid 2% Cream with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong dermatologist prescriptions, high demand in skin infection cases, fast-moving topical antibiotic sales, reliable supply chain support, and good margins in dermatology products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.